NASDAQ : PFSA
Profusa, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 0.7709 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 466.89K
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 424,013 |
| Enterprise Value | 13.81M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 18, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 605,647 |
| Shares Outstanding | 605,647 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +241.66% |
| Owned by Insiders (%) | 14.40% |
| Owned by Institutions (%) | 0.48% |
| Float | 518,170 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.03 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.03 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -725.26% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 117.35% |
| Weighted Average Cost of Capital (WACC) | 28.89% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.86M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -99.97% |
| 50-Day Moving Average | 2.07 |
| 200-Day Moving Average | 94.83 |
| Relative Strength Index (RSI) | 35.95 |
| Average Volume (20 Days) | 2,731,568 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 77,845 |
| Short Previous Month | 160,653 |
| Short % of Shares Out | 12.85% |
| Short % of Float | 15.02% |
| Short Ratio (days to cover) | 0.02 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -31.83M |
| Pretax Income | -42.97M |
| Net Income | -42.97M |
| EBITDA | n/a |
| EBIT | -31.83M |
| Earnings Per Share (EPS) | -$1,983.75 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 719,000 |
| Total Debt | 14.10M |
| Net Cash | -13.39M |
| Net Cash Per Share | -$22.10 |
| Equity (Book Value) | -27.13M |
| Book Value Per Share | -205.03 |
| Working Capital | -27.33M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -20.33M |
| Capital Expenditures | -86,000 |
| Depreciation & Amortization | 2,000 |
| Net Borrowing | 17.11M |
| Free Cash Flow | -20.42M |
| FCF Per Share | -$33.71 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -283,352.32% |
| FCF Yield | -4,814.95% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 17, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |